Erkki Ilveskoski

1.6k citations

57 papers · 1.2k indexed · h-index 21

Cardiology and Cardiovascular Medicine top 5%
Surgery top 10%
Molecular Biology
Epidemiology
Endocrinology, Diabetes and Metabolism top 10%

Co-authors: Pekka J. Karhunen Terho Lehtimäki Markus Perola Tarja Kunnas Jussi Mikkelsson Antti Penttilä Olli A. Kajander Pékka Laippala
Topics: Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers)Lipoproteins and Cardiovascular Health (7 papers)Adipokines, Inflammation, and Metabolic Diseases (5 papers)
Cited by: Cardiology and Cardiovascular Medicine Endocrinology, Diabetes and Metabolism Cancer Research
Journals: Circulation Stroke European Heart Journal
Partner nations: Finland United States Sweden

In The Last Decade

Erkki Ilveskoski

55 papers receiving 1.2k citations

Peers

Countries citing papers authored by Erkki Ilveskoski

Since Specialization

Citations

This map shows the geographic impact of Erkki Ilveskoski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erkki Ilveskoski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erkki Ilveskoski more than expected).

Fields of papers citing papers by Erkki Ilveskoski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erkki Ilveskoski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erkki Ilveskoski. The network helps show where Erkki Ilveskoski may publish in the future.

Co-authorship network of co-authors of Erkki Ilveskoski

This figure shows the co-authorship network connecting the top 25 collaborators of Erkki Ilveskoski. A scholar is included among the top collaborators of Erkki Ilveskoski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erkki Ilveskoski. Erkki Ilveskoski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genetic Basis and Outcome in a Nationwide Study of Finnish Patients with Hypertrophic Cardiomyopathy 2019 ·ESC Heart Failure ·Pertti Jääskeläinen,Jagadish Vangipurapu,(unknown),Teemu Kuulasmaa,Tiina Heliö,Katriina Aalto‐Setälä,Maija Kaartinen,Erkki Ilveskoski,(unknown),(unknown),John Melin,Jorma Kokkonen,Markku S. Nieminen,(unknown),Markku Laakso,Johanna Kuusisto	23
2	Predictors of permanent work disability among ≤50-year-old patients undergoing percutaneous coronary intervention 2015 ·Scandinavian Journal of Work Environment & Health ·Jarmo Gunn,Tuomas Kiviniemi,Fausto Biancari,Olli A. Kajander,Timo Mäkikallio,Markku Eskola,Erkki Ilveskoski,Kari Korpilahti,Jan-Ola Wistbacka,Vesa Anttila,Jouni Heikkinen,Juhani Airaksinen	7
3	Prognosis and disease progression in patients under 50 years old undergoing PCI: The CRAGS (Coronary aRtery diseAse in younG adultS) study 2014 ·Atherosclerosis ·(unknown),Juhani Airaksinen,Tuomas Kiviniemi,Giulia Vinco,Flavio Ribichini,Jarmo Gunn,Vesa Anttila,Jouni Heikkinen,Kari Korpilahti,Pasi P. Karjalainen,Olli A. Kajander,Markku Eskola,Erkki Ilveskoski,Tomas Axelsson,Tómas Guðbjartsson,Anders Jeppsson,Fausto Biancari	17
4	Birthplace in area with high coronary heart disease mortality predicts the severity of coronary atherosclerosis among middle-aged Finnish men who had migrated to capital area: The Helsinki Sudden Death Study 2010 ·Annals of Medicine ·(unknown),Sirkka Goebeler,Erkki Ilveskoski,Jussi Mikkelsson,Markus Perola,(unknown),Pekka J. Karhunen	5
5	Ageing and cardiovascular responses to head-up tilt in healthy subjects 2009 ·Atherosclerosis ·Anna Tahvanainen,Miia Leskinen,Jenni Koskela,Erkki Ilveskoski,Klaus Nordhausen,Hannu Oja,Mika Kähönen,Tiit Kööbi,Jukka Mustonen,Ilkka Pörsti	37
6	COX‐2 Gene Promoter Polymorphism and Coronary Artery Disease in Middle‐Aged Men: The Helsinki Sudden Death Study 2008 ·Mediators of Inflammation ·(unknown),Tarja Kunnas,(unknown),Jussi Mikkelsson,Erkki Ilveskoski,(unknown),(unknown)	17
7	Neuropeptide Y signal peptide Pro7 substitution protects against coronary artery atherosclerosis: The Helsinki Sudden Death Study 2007 ·Atherosclerosis ·Erkki Ilveskoski,Leena E. Viiri,Jussi Mikkelsson,Ilkka Pörsti,Terho Lehtimäki,Pekka J. Karhunen	8
8	Age-dependent association between hepatic lipase gene C-480T polymorphism and the risk of pre-hospital sudden cardiac death: The Helsinki Sudden Death Study 2006 ·Atherosclerosis ·Yue‐Mei Fan,Terho Lehtimäki,Riikka Rontu,Erkki Ilveskoski,Sirkka Goebeler,Olli A. Kajander,Jussi Mikkelsson,Markus Perola,Pekka J. Karhunen	8
9	Toll‐like receptor 4 polymorphism is associated with coronary stenosis but not with the occurrence of acute or old myocardial infarctions 2006 ·Scandinavian Journal of Clinical and Laboratory Investigation ·Jussi Hernesniemi,Terho Lehtimäki,Riikka Rontu,(unknown),Carita Eklund,Jussi Mikkelsson,Erkki Ilveskoski,Olli A. Kajander,Sirkka Goebeler,Leena E. Viiri,Mikko Hurme,Pekka J. Karhunen	18
10	Apolipoprotein E polymorphism is not a predictor for repeated coronary artery bypass surgery 2005 ·Scandinavian Cardiovascular Journal ·Pekka Kuukasjärvi,Matti Tarkka,Ari Mennander,Erkki Ilveskoski,Anna‐Maija Koivisto,Pekka Laippala,Jussi Mikkelsson,Pekka J. Karhunen	1
11	Matrix metalloproteinase 3 and 9 gene promoter polymorphisms: joint action of two loci as a risk factor for coronary artery complicated plaques 2004 ·Atherosclerosis ·(unknown),Terho Lehtimäki,Jussi Mikkelsson,Erkki Ilveskoski,Tarja Kunnas,Markus Perola,Antti Penttilä,Kari M. Mattila,Seppo T. Nikkari,Kirsi Syrjäkoski,Pekka J. Karhunen	32
12	Neuropeptide Y and Alcoholism: Genetic, Molecular, and Pharmacological Evidence 2003 ·Alcoholism Clinical and Experimental Research ·Subhash C. Pandey,Lucinda G. Carr,Markus Heilig,Erkki Ilveskoski,Todd E. Thiele	44
13	Myeloperoxidase Gene Variation as a Determinant of Atherosclerosis Progression in the Abdominal and Thoracic Aorta: An Autopsy Study 2003 ·Laboratory Investigation ·Riikka Mäkelä,Pekka J. Karhunen,Tarja Kunnas,Erkki Ilveskoski,Olli A. Kajander,Jussi Mikkelsson,Markus Perola,Antti Penttilä,Terho Lehtimäki	29
14	A Functional variant of the iNOS gene flanking region is associated with LAD coronary artery disease: an autopsy study 2003 ·European Journal of Clinical Investigation ·Tarja Kunnas,Jussi Mikkelsson,Erkki Ilveskoski,Minna M. Tanner,Pekka Laippala,Antti Penttilä,Markus Perola,Seppo T. Nikkari,Pekka J. Karhunen	7
15	Smoking-dependent association between paraoxonase 1 M/L55 genotype and coronary atherosclerosis in males: an autopsy study 2003 ·Atherosclerosis ·Riikka Rontu,Pekka J. Karhunen,Erkki Ilveskoski,Jussi Mikkelsson,Olli A. Kajander,Markus Perola,Antti Penttilä,Anna‐Maija Koivisto,Terho Lehtimäki	6
16	Methylenetetrahydrofolate reductase gene C677T mutation is related to the defects in the internal elastic lamina of the artery wall 2002 ·European Journal of Clinical Investigation ·(unknown),Otso Järvinen,Tero Sisto,Valtteri Wirta,Erkki Ilveskoski,T. Koivula,Terho Lehtimäki	7
17	Association of Neuropeptide Y Polymorphism With the Occurrence of Type 1 and Type 2 Alcoholism 2001 ·Alcoholism Clinical and Experimental Research ·Erkki Ilveskoski,Olli A. Kajander,(unknown),Tarja Kunnas,Pekka J. Karhunen,(unknown),Matti Virkkunen,Hannu Alho	12
18	Apolipoprotein E polymorphism and atherosclerosis: association of the ε4 allele with defects in the internal elastic lamina 2000 ·Atherosclerosis ·Erkki Ilveskoski,Otso Järvinen,Tero Sisto,Pekka J. Karhunen,Pekka Laippala,Terho Lehtimäki	13
19	Apolipoprotein E ε4 allele frequency is increased in Parkinson's disease only with co-existing Alzheimer pathology 1998 ·Acta Neuropathologica ·P. M. Mattila,Tuomas Koskela,Matias Röyttä,Terho Lehtimäki,Tuula Pirttilä,Erkki Ilveskoski,Pekka J. Karhunen,Juha O. Rinne	28
20	Fast 5-hour determination of angiotensin-converting enzyme genotypes from blood by SDS–PAGE using PhastSystem 1997 ·Clinica Chimica Acta ·Xiaohong Huang,Timo Koivula,Erkki Ilveskoski,Pekka J. Karhunen,Vappu Rantalaiho,Ole Wirta,Amos Pasternack,Terho Lehtimäki	2

About Erkki Ilveskoski

Erkki Ilveskoski is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Periodontics, having authored 57 papers that have together received 1.2k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Lipoproteins and Cardiovascular Health (7 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (407 citations), Endocrinology, Diabetes and Metabolism (172 citations) and Cancer Research (118 citations). Erkki Ilveskoski has collaborated with scholars based in Finland, United States and Sweden. Frequent co-authors include Pekka J. Karhunen, Terho Lehtimäki, Markus Perola, Tarja Kunnas, Jussi Mikkelsson, Antti Penttilä, Olli A. Kajander, Pékka Laippala, Timo Koivula and Sirkka Goebeler. Their work appears in journals such as Circulation, Stroke and European Heart Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact